Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis: (CARE RA)
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
One of the greatest success stories in rheumatology - the achievement of rheumatoid arthritis (RA) remission - is tempered by the fact that individuals with RA are dramatically under evaluated and under treated to reduce the risk for heart attacks and strokes. This project will build the foundation for an intervention that will test the hypothesis that the patient-centered intervention tailored to patients with RA to improve hyperlipidemia screening and treatment, thereby decreasing the risk for heart attacks and strokes.
The aims of this proposal are:
Aim 1: To identify patient and physician barriers to lower the risk for heart attacks and strokes in patients with RA.
Aim 2: To develop an intervention designed to optimize lipid screening and management in RA patients. This will consist of patient education and a decision support program to facilitate screening for hyperlipidemia (high cholesterol level) or initiation of medications to lower cholesterol (primary outcome) and self-efficacy (level of confidence in performing a task) in taking medications to lower cholesterol secondary outcome).
Aim 3: To pilot test the efficacy and feasibility of intervention developed in Aim 2. The investigators will apply methods related to clinical trials to test the feasibility of the newly developed intervention.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Have RA
- Age between 40 and 75 years (inclusive)
- Provide a date of their next appointment with their rheumatologist or other physician on their care team
- Willing to work with a peer coach
- Speaks English
- Have a phone
- Has access to the internet
- Resides or lives in the US
Exclusion criteria
-
Do not have rheumatoid arthritis
-
Younger than age 40 or older than age 75
-
Taking a statin
-
No known history of diabetes
-
No known history of CVD defined by:
- Open heart surgery
- Coronary angioplasty
- History of heart failure
- History of heart attack or stroke
Trial design
Primary purpose
Allocation
Interventional model
Masking
79 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Central trial contact
Iris Navarro-Millan, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal